TARGET AUDIENCe
LEARNING OBJECTIVES
By the conclusion of this activity, participants should be able to:
- Appraise new and upcoming technologies in the management of structural heart disease, including, valvular heart disease, stroke prevention, hemodynamic support, cardiomyopathy and high risk-percutaneous coronary intervention to demonstrate their benefit for patients.
- Evaluate the relative advantages and disadvantages of different strategies in complex cases involving valvular heart diseases. Present indications, techniques, outcomes, and complications for transcatheter valve intervention in patients with native valve lesions.
- Compare FDA approved technologies for TAVR and the scientific data supporting their use.
- Recognize the different diagnostic tools and combinations required to accurately diagnose specific structural heart diseases and plan transcatheter therapies.
- Discuss rationale and technique of alternative access approach for aortic stenosis.
- Discuss investigational valves in the near horizon including their therapeutic advantages and limitations.
- Discuss transcatheter treatment options for mitral and tricuspid valve disease as well as the new upcoming investigational devices.
- Examine the data and techniques for identification and assessment of hemodynamically significant coronary artery lesions as well as the presence or absence of microvascular disease.
- Examine the data and techniques for coronary imaging and lesion characterization and their impact on percutaneous revascularization outcomes.
- Assess the benefits of using mechanical circulatory support for the treatment of high-risk severe coronary artery disease as well as in the management of shock.
- Identify the indication, techniques and complications for left atrial appendage occlusion in patients with afib.
- Evaluate patients for advanced heart failure therapies.
CME ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Behind the Scenes (BTS). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Professions in scope are listed below. Amedco Joint Accreditation Provider Number: 4008163.
2025 CME CREDIT DESIGNATION STATEMENT
Physicians
Amedco LLC designates this live activity for a maximum of 16.00 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioners
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit.
Physician Assistants
The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 CreditsTM are acceptable for continuing medical education requirements for recertification for PAs.
Amedco LLC designates this live activity for a maximum of 16.00 AMA PRA Category 1 CreditsTM for physicians. PAs should claim only the credit commensurate with the extent of their participation in the activity.
2025 OTHER CREDITS
- For the purpose of recertification, the American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.
- The American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.
- The American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the ACCME. Physician assistants may receive a maximum of 16.00 hours of Category 1 credit for completing this program.
UEMS/EACCME CME CREDIT RECOGNITION
The American Medical Association (AMA) has an agreement of mutual recognition of CME credit with the UEMS. Under the terms of this agreement the European Accreditation Council for Continuing Medical Education (EACCME), the accrediting arm of the UEMS, will convert CME credit for live activities certified by the AMA.
Disclaimer
Behind the Scenes and Amedco LLC make every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Behind the Scenes and Amedco LLC must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, and planning committee members participating in an activity sponsored by BTSCME are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Behind the Scenes requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.